Over the past 30 years, scientists have synthesized a series of neuropeptides (like those occurring naturally in the brain) that offer huge potential for treating neurological diseases—from depression to Alzheimer’s. But there’s a problem: these neuropeptides are metabolized on their way to the brain. Working at the IU School of Medicine, Professor Michael Kubek and… Read more »